Mark L. Jacobson is Chief Operating Officer of Axsome Therapeutics, Inc.. Currently has a direct ownership of 5,783 shares of AXSM, which is worth approximately $513,761. The most recent transaction as insider was on Aug 09, 2024, when has been sold 47,739 shares (Common Stock) at a price of $84.26 per share, resulting in proceeds of $4,022,488. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.78K
0% 3M change
n/a 12M change
Total Value Held $513,761

Mark L. Jacobson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2024
SELL
Open market or private sale
$4,022,488 $84.26 p/Share
47,739 Reduced 89.2%
5,783 Common Stock
Aug 09 2024
BUY
Exercise of conversion of derivative security
$192,865 $4.04 p/Share
47,739 Added 47.14%
53,522 Common Stock
May 29 2024
SELL
Open market or private sale
$587,792 $74.31 p/Share
7,910 Reduced 57.77%
5,783 Common Stock
May 29 2024
BUY
Exercise of conversion of derivative security
$17,800 $1.3 p/Share
13,693 Added 50.0%
13,693 Common Stock
Apr 01 2024
SELL
Open market or private sale
$1,904,892 $77.24 p/Share
24,662 Reduced 100.0%
0 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
$32,060 $1.3 p/Share
24,662 Added 50.0%
24,662 Common Stock
MLJ

Mark L. Jacobson

Chief Operating Officer
New York, NY

Track Institutional and Insider Activities on AXSM

Follow Axsome Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

News

Receive news related to Axsome Therapeutics, Inc.

Track Activities on AXSM